#EU: Using the authorization process for GMOs also for new genomic techniques presents a high #investment barrier, meaning it is unlikely that companies develop new plants for cultivation in the EU—which hurts the competitiveness of its agriculture: doi.org/10.1093/erae... #PlantBreeding #Regulation
Abstract. We examine the economic impact of regulating new genomic techniques on investment decisions in the EU. Using a real options model, we compare fiv
